PALO ALTO, Calif., & LOUISVILLE, Colo.--(BUSINESS WIRE)--Science Exchange, the world’s leading and most secure enterprise platform for outsourced research and development, is proud to announce that Elion Labs, provider of analytical development and drug product characterization services, will present exciting new research at the 2017 AAPS (American Association of Pharmaceutical Scientists) Annual Meeting, the most comprehensive event for innovations in bioanalysis, formulation, and product characterization.
Elion’s expertise has helped bring numerous clinical products to market. Their AAPS research poster presentation (Abstract M8003) introduces a novel method for drug product analysis, using machine learning and advanced image analysis to improve particle detection, enumeration, and classification.
“Machine learning approaches open up exciting new possibilities for analyzing particles in biologics, and ultimately, for better analyzing a broad range of complex data sets,” said John Gabrielson, Ph.D., CEO and Founding Partner of Elion Labs. “We hope that our research will help biopharmaceutical researchers develop safer, more effective drugs and deliver them to patients faster.”
Elion and Science Exchange will exhibit at booth 2337 at AAPS, meeting drug discovery and development researchers and representatives of regulatory agencies seeking the latest, innovative services available for pharmaceutical analysis.
“We’re proud to participate in this year’s conference alongside Elion, who are true thought leaders in analytical research,” said Elizabeth Iorns, Ph.D., CEO and Co-Founder of Science Exchange. “And because they’re part of the Science Exchange network, biopharmaceutical researchers can access Elion’s technologies immediately under our pre-existing master service agreement that covers IP and confidentiality.”
More information about Elion Labs and their innovative services can be found at www.scienceexchange.com/labs/elion-labs.
About Science Exchange
Science Exchange is the world's
leading and most secure platform for outsourced research, providing an
efficient procure-to-pay platform for ordering 6,000+ services from a
network of more than 2,500 qualified scientific service providers, all
with pre-established contracts in place that protect client intellectual
property and confidentiality. The platform increases access to
innovation and improves productivity, freeing scientists from
administrative tasks and delays associated with sourcing, establishing
and managing service provider contracts. Additionally, the Science
Exchange enterprise program enables large R&D organizations to
consolidate research outsourcing spend into a single strategic
relationship, driving efficiency, improving transparency and oversight,
and delivering cost savings. Since being founded in 2011, Science
Exchange has raised more than $58 million from Norwest Venture Partners,
Maverick Capital Ventures, Union Square Ventures, Collaborative Fund,
Index Ventures, OATV, the YC Continuity Fund, and others. For more
information, visit www.ScienceExchange.com.
Follow the company on Twitter @ScienceExchange.
About Elion Labs
Elion Labs, based in Louisville, Colorado,
USA, was founded to serve the analytical development and product
characterization needs of the biopharmaceutical industry. Elion offers a
variety of services, including analytical method development,
qualification and validation; analytical characterization testing of
biologics; formulation development; training in highly specialized
analytical techniques; comprehensive data analysis including
visualization and interpretation of complex data sets; technical and
regulatory writing; and technical consulting. They are committed to
providing all services with unmatched professionalism, quality, and
speed.
